Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2019
DOI: 10.3389/fimmu.2019.01290
|View full text |Cite
|
Sign up to set email alerts
|

Dermatitis Herpetiformis: Novel Perspectives

Abstract: Dermatitis herpetiformis (DH) is an inflammatory disease of the skin, considered the specific cutaneous manifestation of celiac disease (CD). Both DH and CD occur in gluten-sensitive individuals, share the same Human Leukocyte Antigen (HLA) haplotypes (DQ2 and DQ8), and improve following the administration of a gluten-free diet. Moreover, almost all DH patients show typical CD alterations at the small bowel biopsy, ranging from villous atrophy to augmented presence of intraepithelial lymphocytes, as well as th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
69
0
34

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 74 publications
(120 citation statements)
references
References 195 publications
(233 reference statements)
1
69
0
34
Order By: Relevance
“…Proteolytic gliadin peptides from ingested gluten induce production of IgA class autoantibodies against both native and gliadin-associated tissue transglutaminase 2 (TG2) (2). These antibodies are detectable in the serum and small bowel mucosa of CD patients, but in only about 75% of DH patients (6,7). Typically the sera of DH patients contain anti-epidermal transglutaminase (TG3) IgA autoantibodies, which show up on direct immunofluorescence microscopy (DIF) analysis of the skin as granular IgA deposits in the papillary dermis (8,9).…”
Section: Introductionmentioning
confidence: 99%
“…Proteolytic gliadin peptides from ingested gluten induce production of IgA class autoantibodies against both native and gliadin-associated tissue transglutaminase 2 (TG2) (2). These antibodies are detectable in the serum and small bowel mucosa of CD patients, but in only about 75% of DH patients (6,7). Typically the sera of DH patients contain anti-epidermal transglutaminase (TG3) IgA autoantibodies, which show up on direct immunofluorescence microscopy (DIF) analysis of the skin as granular IgA deposits in the papillary dermis (8,9).…”
Section: Introductionmentioning
confidence: 99%
“…The association between HMs and subepidermal autoimmune bullous dermatoses other than BP mostly relies on single case reports or small series, and almost always involves lymphoproliferative disorders. Worth mentioning are cases of linear IgA bullous dermatosis associated with B-cell chronic lymphatic leukaemia, acute lymphoblastic leukaemia and Hodgkin’s lymphoma [ 166 169 ]; epidermolysis bullosa acquisita with multiple myeloma, mantle cell lymphoma and B-cell chronic lymphatic leukaemia [ 170 174 ]; laminin 332-type mucous membrane pemphigoid with non-Hodgkin’s lymphoma; and dermatitis herpetiformis with non-Hodgkin’s lymphoma of the gastrointestinal tract [ 175 ].…”
Section: Autoimmune Blistering Dermatosesmentioning
confidence: 99%
“…Dermatitis Herpetiformis (DH) is a chronic, autoimmune, and recurrent cutaneous-intestinal disorder identified in genetically susceptible individuals, which is often associated with CD [67,68]. Anti-tTG antibodies that are produced in response to gluten exposure can also recognize epidermal transglutaminase (ETG).…”
Section: Dermatitis Herpetiformis (Dh)mentioning
confidence: 99%